A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Patents for A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707)
11/2002
11/13/2002	EP1255854A2 Interaction of nmda receptor with protein tyrosine phosphatase
11/13/2002	EP1255829A2 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization
11/13/2002	EP1255748A1 Beta-alanine derivatives and their use as receptor antagonists
11/12/2002	US6479523 Achieved by electrical stimulation of the vagus nerve and administration of a combination of drugs including: an acetylcholinesterase inhibitor, a beta-adrenergic receptor blocker, and a calcium channel blocker
11/12/2002	US6479470 Naag and naaladase have been implicated in several pathological conditions relating to glutamate abnormalities and neurotoxicity
11/07/2002	WO2002088095A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002	US20020165343 Growth hormone secretagogues
11/07/2002	US20020164794 Pluripotent somatic stem cells for use in regenerative medicine
11/07/2002	CA2446514A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/06/2002	EP1254270A1 Methods and materials relating to cub domain polypeptides and polynucleotides
11/06/2002	EP1254138A1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
10/2002
10/31/2002	WO2002085940A2 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002	WO2002085899A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002	WO2002058750A3 A suspension comprising fibrinogen, thrombin and alcohol and a method of coating a carrier with the same
10/31/2002	WO2002022611A3 Caspase inhibitors and uses thereof
10/31/2002	WO2002004002A3 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
10/31/2002	US20020161237 (Z)-2-((2-bromo-4-(((3-hydroxybenzyl)amino)carbonyl)benzoyl) -amino)pent-2-enoic acid, for example; useful for treating psoriasis
10/31/2002	US20020160000 PD-1, a receptor for B7-4, and uses therefor
10/31/2002	CA2443600A1 Heterocyclyldicarbamides as caspase inhibitors
10/31/2002	CA2443373A1 New polynucleotides and polypeptides of the erythropoietin gene
10/30/2002	EP1252333A2 Methods and materials relating to cd84-like polypeptides and polynucleotides
10/30/2002	EP1251853A1 Transdermal therapeutic system for the administration of zaleplon
10/30/2002	CN1377266A Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion
10/29/2002	US6472379 Angiogenesis inhibition
10/24/2002	WO2002083125A1 Method of inhibiting adhesion formation
10/24/2002	CA2443734A1 Method of inhibiting adhesion formation
10/23/2002	EP0772446B1 Anti-adhesion agent
10/22/2002	US6469229 Inbred miniature swine and uses thereof
10/22/2002	US6468960 Therapeutic compositions and methods for enhancing angiogenesis
10/16/2002	EP1248801A1 Human polynucleotides, polypeptides, and antibodies
10/16/2002	EP1248636A1 Dextrin containing compositions for prevention of adhesions
10/10/2002	WO2002079175A1 3-heterocyclylpropanohydroxamic acid pcp inhibitors
10/10/2002	WO2002060386A3 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF IλB KINASE (IKK)
10/10/2002	WO2002058749A3 Carrier with solid fibrinogen and solid thrombin
10/10/2002	WO2002041827A3 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
10/10/2002	US20020147231 Allosteric adenosine receptor modulators
10/10/2002	US20020147185 Antihypoxic agents, antiischamic agents, antiarrhythmia agents
10/09/2002	EP1246590A1 Local prevention or amelioration of pain from surgically closed wounds
10/08/2002	US6462082 Use of hydroxyeicosatetraenoic acid derivatives in intraocular surgery
10/03/2002	WO2001071004A3 Proteases
10/03/2002	US20020143004 Allosteric adenosine receptor modulators
10/03/2002	US20020142353 Connective tissue growth factor (CTGF) and methods of use
10/02/2002	EP1244790A2 Nucleic acids encoding polypeptides having chips activity
10/02/2002	EP1244454A2 Use of 2-amino-3,4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions
10/02/2002	CN1372450A Enhanced wound converage to enhance wound healing
10/02/2002	CN1371692A Medicine for preventing tissue from adhersion after operation
09/2002
09/26/2002	WO2002074346A2 Targeting chemical compounds to cells
09/26/2002	WO2002074056A2 Allosteric adenosine receptor modulators
09/26/2002	WO2002032461A3 Protein c or activated protein c-like molecules
09/26/2002	WO2000027868A9 Connective tissue growth factor (ctgf) and methods of use
09/26/2002	US20020137686 Inhibitors of the ICE/ced-3 family of cysteine proteases
09/26/2002	US20020136719 For biomedical applications, including biological delivery to humans and animals
09/26/2002	CA2441563A1 Allosteric adenosine receptor modulators
09/26/2002	CA2441111A1 Method for targeting chemical compounds to cells and pharmaceutical compositions used therein
09/25/2002	EP1242097A2 Pharmaceutical composition comprising a vanadium compound and at least a component selected from a na+/h+ exchanger, cyclo-oxygenase inhibitors and caspase inhibitors
09/25/2002	CN1371286A Use of cyclooxygenase-2 inhibitor matrix metallappoteinase inhibitor antineoplastic agent and optionally radiation as combination treatment of neoplasia
09/25/2002	CN1370539A Prepn of isolator for preventing post-operation adhesion of abdominal cavity
09/25/2002	CN1370531A Combined therapy
09/25/2002	CN1091378C Changtong inflammation relieving and pain-stopping oral liquor
09/19/2002	WO2002072636A2 Crystals of whole antibodies and fragments thereof and methods for making and using them
09/19/2002	WO2002014350A3 Peptide and peptide mimetic derivatives with integrin inhibitor properties ii
09/19/2002	US20020132763 Deuterated cyclosporine analogs and their use as immunomodulating agents
09/19/2002	CA2433353A1 Crystals of whole antibodies and fragments thereof and methods for making and using them
09/18/2002	EP1241176A1 Purine derivatives for the treatment of ischemia
09/18/2002	EP1240265A2 1,1-disubstituted ethylene adhesive compositions containing polydimethylsiloxane
09/18/2002	EP1240160A1 Substituted pyridazines having cytokine inhibitory activity
09/16/2002	CA2376738A1 Purine derivatives for the treatment of ischemia
09/12/2002	WO2002070594A2 A method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge
09/12/2002	US20020128725 Process and composition for medical use
09/12/2002	US20020128527 Use in medicine, pharmacy, biology and technology, friction-reducing additives in engines
09/12/2002	US20020128512 Biscarbodiimides, bisthiourea derivatives, bisurea derivatives having a disulfide bond; crosslinking hyaluronic acids and dervivatives to form high viscosity sustained release, drug delivery agents; eye surgery; tissue engineering
09/12/2002	US20020128285 Topical delivery of a local anesthetic
09/12/2002	US20020128267 Especially celecoxib, deracoxib, valdecoxib, a benzopyran COX-2 inhibitor, parecoxib, rofecoxib etoricoxib, or a 2-(3,5-difluorophenyl)-3-(4-(methylsulfonyl)phenyl) -substituted cyclopentenone, or pyridazinone
09/12/2002	US20020128222 Methods to enhance wound healing and enhanced wound coverage material
09/11/2002	EP1237917A2 Protein c derivatives
09/11/2002	EP1091775B1 Diphasic injection composition, in particular useful in reparative and plastic surgery
09/11/2002	EP0901385B1 Injectable compositions and their preparation.
09/06/2002	WO2002068383A2 Thiol-modified hyaluronan
09/06/2002	WO2002036771A3 Imaging, diagnosis and treatment of disease
09/06/2002	WO2002010348A3 Tissue implant for cartilage repair
09/06/2002	CA2437417A1 Thiol-modified hyaluronan
09/05/2002	US20020123632 Substituted anthranilic acids, their use as a medicament or diagnostic, and medicament comprising them, and a pharmaceutical combination preparation containing a sodium/hydrogen exchange (NHE) blocker
09/04/2002	EP1235860A2 G-protein coupled receptors
09/04/2002	EP1235618A2 Bioconjugation in vivo to pulmonary or blood components
08/2002
08/29/2002	WO2001096547A3 Human kinases
08/29/2002	WO2000059515A9 Immunomodulating polymers
08/29/2002	US20020119967 Autoimmune diseases; administering phosphodiesterases inhibitor
08/28/2002	EP1233963A2 Novel sulfonyl oxazole amines
08/28/2002	EP1233786A2 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance
08/28/2002	EP1233767A1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion
08/27/2002	US6440950 Selective and non-invasive visualization or treatment of vasculature
08/27/2002	US6440948 Thiophene A2A receptor agonists
08/22/2002	WO2002064748A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/22/2002	US20020115156 Connective tissue growth factor for use in the treatment of cancer, fibrotic defects and atherosclerosis; for use as wound healing agents
08/22/2002	CA2438501A1 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
08/21/2002	EP1231982A2 Use of phthalazine derivatives
08/21/2002	EP0637203B1 Regulation of the immune system
08/20/2002	US6436425 Administering aqueous formulation comprising polyoxyalkylene block cpolymer and water to tissues of mammal for inhibiting the formation/reformation of internal adhesions
08/20/2002	US6436393 Adenoviral vector encoding anti-apoptotic Bcl-2 gene and uses thereof
08/15/2002	WO2002062351A1 A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis

1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38